- Home
- FNWB vs PLRX Comparison
FNWB vs PLRX Comparison
Compare FNWB & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- PLRX
- Stock Information
- Founded
- FNWB 1923
- PLRX 2015
- Country
- FNWB United States
- PLRX United States
- Employees
- FNWB N/A
- PLRX N/A
- Industry
- FNWB Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- PLRX Health Care
- Exchange
- FNWB Nasdaq
- PLRX Nasdaq
- Market Cap
- FNWB 87.2M
- PLRX 87.0M
- IPO Year
- FNWB 2015
- PLRX 2020
- Fundamental
- Price
- FNWB $9.81
- PLRX $1.50
- Analyst Decision
- FNWB Hold
- PLRX Hold
- Analyst Count
- FNWB 1
- PLRX 10
- Target Price
- FNWB $12.00
- PLRX $9.79
- AVG Volume (30 Days)
- FNWB 15.1K
- PLRX 1.3M
- Earning Date
- FNWB 04-28-2025
- PLRX 05-05-2025
- Dividend Yield
- FNWB 2.84%
- PLRX N/A
- EPS Growth
- FNWB N/A
- PLRX N/A
- EPS
- FNWB N/A
- PLRX N/A
- Revenue
- FNWB $50,900,000.00
- PLRX N/A
- Revenue This Year
- FNWB $42.48
- PLRX N/A
- Revenue Next Year
- FNWB $11.60
- PLRX N/A
- P/E Ratio
- FNWB N/A
- PLRX N/A
- Revenue Growth
- FNWB N/A
- PLRX N/A
- 52 Week Low
- FNWB $8.91
- PLRX $1.10
- 52 Week High
- FNWB $12.10
- PLRX $16.52
- Technical
- Relative Strength Index (RSI)
- FNWB 43.79
- PLRX 39.12
- Support Level
- FNWB $9.55
- PLRX $1.10
- Resistance Level
- FNWB $9.94
- PLRX $1.59
- Average True Range (ATR)
- FNWB 0.44
- PLRX 0.12
- MACD
- FNWB -0.03
- PLRX 0.14
- Stochastic Oscillator
- FNWB 21.49
- PLRX 81.63
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.